Kaynes Technology India
EMS + semiconductor (OSAT/PCB)
- Last close
- ₹3,511.50
- 29 Sept 2026 · reference
- 1D · 1M
- −4.0% · −10.9%
- price-only
- Weight
- 2.4%
- 31 Jul 2026 · Aug rank 12
- Thesis review
- 8 Sep 2026
- Why We Own, p46
EMS + semiconductor (OSAT/PCB) — what has to happen, what we believe, what breaks it
- Q3FY27 (Oct-Dec 2026): commercial ramp of Sanand OSAT and Chennai PCB plants; first meaningful component revenue.
- Q2FY27 results (Nov-2026): evidence of working-capital normalisation and margin recovery toward 17% guidance.
- ISM 2.0 / ECMS approvals and any anchor OSAT customer announcements (Kaynes was linked to advanced-node packaging news in 2026).
- Fastest-growing listed Indian EMS at scale: 5-yr sales CAGR 54% and PAT CAGR 104% (screener); FY26 revenue +33% to Rs 3,626 cr and Q1FY27 +40%; management guides ~30% FY27 growth ('2x industry') and ~17% EBITDA margin.
- Order book Rs ~8,900 cr (+20% YoY) = ~2.3x FY26 revenue, weighted to industrial, auto and aerospace/defence where margins (16%) are 5x Dixon's mobile-EMS margins (2.6-3.0%).
- OSAT + PCB step-up: Rs 1,250 cr invested to date (Rs 700 cr OSAT with Rs 170 cr subsidy received; Rs 500 cr PCB), both to reach operational readiness by Q3FY27 with a combined Rs 450-500 cr revenue target in FY27 and higher-margin component revenue thereafter; Sanand shipped India's first commercial multi-chip module in Mar-26.
- Policy tailwind: India EMS market $40-45 bn in FY25 heading past $150 bn by FY30 (KPMG, Jun-26) and MOFSL's Rs 6 lakh cr FY27 EMS estimate (26% CAGR); ISM 2.0/ECMS incentives directly subsidise Kaynes' OSAT/PCB capex.
- Valuation reset: 1-yr price -49% while EPS grew 19% in FY26; Buoyant's FY28e P/E 46.6x vs MOFSL's 52% PAT CAGR gives a PEG <1 if the OSAT/PCB ramp lands.
- Core · Small cap2.4% of PMS · rank 12
- Working capital and cash burn: debtor days 154 and working-capital days 133 at Mar-26 (from 64), FY26 operating cash flow -Rs 600 cr; net debt rose to ~Rs 800 cr in Q1FY27 - growth is being funded by the balance sheet.
- Execution/timing of OSAT and PCB: both slipped to Q3FY27 readiness; yields, customer qualification and subsidy timing could delay the Rs 450-500 cr FY27 contribution and keep ROE at 9-11% (Buoyant FY27e ROE 11.3%).
- Promoter holding fell 10.1% over 3 years (53.46% at Jun-26) on QIP dilution; further equity raises for semiconductor capex would dilute EPS.
Thesis and position rationale
- Investment case
- EMS + semiconductor (OSAT/PCB)
- Why this business
Mysuru-based end-to-end electronics manufacturing services (EMS) company doing design-led box-build and PCB assembly for automotive, industrial, aerospace/defence, railways, medical and IoT customers - a high-mix, higher-margin niche (16% EBITDA margin vs Dixon's ~3%). It is building India's first commercial OSAT (semiconductor packaging) plant at Sanand, Gujarat (commercialised Mar-2026, multi-chip module shipped) and a bare-PCB/HDI plant in Chennai (Kaynes Circuits), to move up from assembly into components. FY26 revenue Rs 3,626 cr; order book ~Rs 8,900 cr (+20% YoY) at Jun-26.
- What we believe
- 01Fastest-growing listed Indian EMS at scale: 5-yr sales CAGR 54% and PAT CAGR 104% (screener); FY26 revenue +33% to Rs 3,626 cr and Q1FY27 +40%; management guides ~30% FY27 growth ('2x industry') and ~17% EBITDA margin.
- 02Order book Rs ~8,900 cr (+20% YoY) = ~2.3x FY26 revenue, weighted to industrial, auto and aerospace/defence where margins (16%) are 5x Dixon's mobile-EMS margins (2.6-3.0%).
- 03OSAT + PCB step-up: Rs 1,250 cr invested to date (Rs 700 cr OSAT with Rs 170 cr subsidy received; Rs 500 cr PCB), both to reach operational readiness by Q3FY27 with a combined Rs 450-500 cr revenue target in FY27 and higher-margin component revenue thereafter; Sanand shipped India's first commercial multi-chip module in Mar-26.
- 04Policy tailwind: India EMS market $40-45 bn in FY25 heading past $150 bn by FY30 (KPMG, Jun-26) and MOFSL's Rs 6 lakh cr FY27 EMS estimate (26% CAGR); ISM 2.0/ECMS incentives directly subsidise Kaynes' OSAT/PCB capex.
- 05Valuation reset: 1-yr price -49% while EPS grew 19% in FY26; Buoyant's FY28e P/E 46.6x vs MOFSL's 52% PAT CAGR gives a PEG <1 if the OSAT/PCB ramp lands.
- Why now
TTM P/E 71x; stock is -49% over 1 year (52-wk range Rs 2,995-7,705) so the multiple has compressed sharply from >100x at the 2025 peak, though 5-yr average P/E not sourced. EV/EBITDA computed on Rs 25,466 cr EV (mcap + ~Rs 800 cr net debt) / TTM EBITDA Rs 609 cr. EV/EBITDA 41.8x; dividend yield 0.0%.
- Market disagreement
- Dixon Technologies: Dixon (P/E 46x, mcap Rs 86,679 cr) is 92% mobile/EMS at 2.6-3.0% EBITDA margin with ROCE falling to 34% from 45% after Mobile PLI 1.0 expiry; Kaynes has 5x the margin, a 2.3x order-book cover and component (OSAT/PCB) optionality Dixon lacks.
- Syrma SGS: Syrma (P/E 85x, ROE 14%, FY26 PAT Rs 346 cr) is priced higher than Kaynes on trailing earnings with a more consumer/auto-commodity mix and no semiconductor/PCB backward-integration programme.
- Amber Enterprises: Amber (P/E 127x, ROE 6%) is a seasonal RAC-component business (Q1FY27 PAT just Rs 3 cr on Rs 3,888 cr sales) with lower margins and heavier capex intensity; Kaynes' industrial/defence mix is less seasonal and higher margin.
- Position sizing
Core Small cap 2.4% of the PMS on $31 Jul 2026 (August rank 12). Core positions are owned through the cycle for leadership and cash-flow quality.
- Catalysts
- Q3FY27 (Oct-Dec 2026): commercial ramp of Sanand OSAT and Chennai PCB plants; first meaningful component revenue.
- Q2FY27 results (Nov-2026): evidence of working-capital normalisation and margin recovery toward 17% guidance.
- ISM 2.0 / ECMS approvals and any anchor OSAT customer announcements (Kaynes was linked to advanced-node packaging news in 2026).
- Risks and response
- Working capital and cash burn: debtor days 154 and working-capital days 133 at Mar-26 (from 64), FY26 operating cash flow -Rs 600 cr; net debt rose to ~Rs 800 cr in Q1FY27 - growth is being funded by the balance sheet.
- Execution/timing of OSAT and PCB: both slipped to Q3FY27 readiness; yields, customer qualification and subsidy timing could delay the Rs 450-500 cr FY27 contribution and keep ROE at 9-11% (Buoyant FY27e ROE 11.3%).
- Promoter holding fell 10.1% over 3 years (53.46% at Jun-26) on QIP dilution; further equity raises for semiconductor capex would dilute EPS.
- Thesis-break conditions
- Not stated separately on this page; the risk list carries the monitoring triggers.
- Review history
- 8 Sep 2026 · Yash Palod · one-pager in "Why We Own What We Own" (p46) · portfolio as of $31 Jul 2026
- 31 Aug 2026 · Classification in the August top-30: Turnaround (July book: Core)
Source: Buoyant_Why_We_Own_What_We_Own_Sep2026.pdf (portfolio as of 31 July 2026), p46. Internal; external publication of these fields is controlled by audience policy.
Internal actions
- HoldPosition carried into August at rank 12.
- ReviewNext scheduled: post 2QFY27 results (Oct–Nov 2026).
Add/trim/exit decisions require transactions data; none supplied. Recording a decision needs a persistence adapter (not configured).
Sector datapoints
- India EMS market grew from ~$10-12 bn (FY20) to $40-45 bn (FY25) and could exceed $150 bn by FY30 (KPMG India report, Jun-2026); ~$19.5 bn cumulative incentives; 80-95% import dependence on critical components.
- MOFSL projects India EMS at Rs 6 lakh cr in FY27 from Rs 1.46 lakh cr in FY22, a 26% CAGR to $500 bn by 2030 (Dec-2024 report).
- Kotak expected 21% YoY revenue and 18% EBITDA growth for its EMS coverage in Q1FY27 (10-Jul-2026), with margin pressure from raw materials/memory prices and PLI 1.0 expiry; Dixon Q1FY27 adj. margin fell 80 bps to 3.0%.
- Policy: Mobile PLI 2.0 and ISM 2.0 proposed (2026); Kaynes received Rs 170 cr of subsidies against its Sanand OSAT.